Pharmacogenetics of antihypertensive treatment

Pharmacogenetic association of the NR1H3 promoter variant with ...

The associations of 11 candidate variants with blood pressure changes in response to antihypertensive drugs and with the risk of cardiovascular ...

Pharmacogenetics of the response to antihypertensive drugs

Hypertension pharmacogenetics seeks to find genetic predictors of response to drugs that reduce blood pressure or unfavorable cardiovascular ...

Pharmacogenetics of Antihypertensive Treatment - Scholars@UK

Pharmacogenetics of Antihypertensive Treatment ; Hypertension · A Companion to Braunwald's Heart Disease: Second Edition · 410-415 · 6 · https://doi.org/10.1016/B978 ...

Pharmacogenomics considerations in the control of hypertension.

Discussed In Paper More information · Ace Inhibitors, Plain · Angiotensin II Antagonists · Beta Blocking Agents · Calcium channel blockers · diuretics ...

The Pharmacogenomics of AntiHypertensive Therapy - ResearchGate

9 Thus, the goal of hypertension pharmacogenomics is to use genetic information, in addition to other pertinent clinical or demographic parameters, to select ...

Pharmacogenomics of antihypertensive drugs

The low response rates to any particular antihypertensive drug suggest the current approach to therapy selection and hypertension management is not optimal. The ...

The Pharmacogenomics of Anti-Hypertensive Therapy - MDPI

Hypertension pharmacogenomics seeks to find genetic predictors of response to drugs that lower blood pressure and to translate this knowledge into clinical ...

Pharmacogenetics: Therapeutic regimen in hypertension

Pharmacogenetics in hypertension is a growing field that seeks to personalize the treatment of this common cardiovascular condition. By ...

Pharmacogenomic studies of hypertension

beta-blocker pharmacogenetics and treatment-related outcomes in hypertension ... antihypertensive treatment: the Genetics of Hypertension-Associated Treatment ( ...

Antihypertensive pharmacogenetics: getting the right drug into the ...

Antihypertensive pharmacogenetics: getting the right drug into the right patient ... drugs reveal hypertension mechanisms and simplify treatment.

Pharmacogenetics of hypertension treatment: a structured review.

Genetic predictors (mainly single nucleotide polymorphisms, SNPs) have been the focus of several recent studies and are gaining much attention. We have ...

Pharmacogenetics of hypertension treatment: a structured review

Pharmacogenetics of hypertension treatment: a structured review. Richard P ... Genetics of blood pressure, hypertensive complications, and antihypertensive drug ...

Pharmacogenetics of antihypertensive treatment - Academia.edu

Evidence also suggests that the blood pressure response to antihypertensive drugs has a genetic component. As background, for any given gene, there may be ...

Pharmacogenetics of hypertension treatment - LWW

Biochemical approaches, such as renin profiling, and demographic factors, such as age, gender and ethnicity, have been proposed as useful predictors of ...

Exploring Pharmacogenetic Testing for Hypertension Management ...

Back Article ; [7], Schwartz GL, Turner ST. Pharmacogenetics of antihypertensive drug responses. Am J Pharmacogenomics 2004;4(3):151 − 60. http://dx.doi.org/ ...

Pharmacogenomics of Antihypertensive Treatment & Clinical ...

Pharmacogenomics of Antihypertensive Treatment & Clinical. Pharmacological Studies of Digoxin Treatment. Acta Universitatis Upsaliensis. Digital.

Pharmacogenomics of antihypertensive drugs: past, present and ...

Hypertension pharmacogenomics holds the promise of leading to individualized drug treatment approaches for the approximately 1 billion individuals worldwide ...

An update on the pharmacogenetics of treating hypertension | Scilit

Genetic polymorphisms may partially account for the interindividual variability and abnormal response to antihypertensive drugs. Candidate gene and genome-wide ...

An update on the pharmacogenetics of treating hypertension

Interpretation Although the control rate (40·4%) improved for treated hypertension compared with that (31·6%) in 2010, most patients did not ...

Pharmacogenomics of Hypertension Treatment - OUCI

This article reviews the recent pharmacogenomics literature concerning the key classes of antihypertensive drugs currently in use (i.e., diuretics, β-blockers, ...